1. Vane JR. Towards a better aspirin. Nature 1994;367:215–6.
2. Engelhardt G. Meloxicam inhibits preferentially COX-2. Europ J Clin Pharmacol 1994;47:A98.
3. Engelhardt G, Bögel R, Krug I, Walcher I. Meloxicam: Lack of correlation between inhibition of PG biosynthesis in the inflammatory area and in the stomach. Magy Rheumatol 1991;32(Suppl):354.
4. Busch U. Pharmacokinetics of meloxicam in animals. Scand J Rheumatol 1994;(Suppl)98:A119.
5. Türk D, Busch U, Heinzel G, Narjes H. Basic clinical pharmacokinetic of meloxicam, a new NSAID. Scand J Rheumatol 1994;(Suppl)98:A120.